Aimmune Therapeutics Uk Limited CHELTENHAM

Founded in 2015, Aimmune Therapeutics Uk, classified under reg no. 09559128 is an active company. Currently registered at Carrick House GL50 2QJ, Cheltenham the company has been in the business for 4 years. Its financial year was closed on December 31 and its latest financial statement was filed on Sun, 31st Dec 2017.

The firm has 2 directors, namely Eric B., Douglas S.. Of them, Douglas S. has been with the company the longest, being appointed on 31 March 2017 and Eric B. has been with the company for the least time - from 16 November 2018. As of 29 September 2019, there were 3 ex directors - Susan B., Warren D. and others listed below. There were no ex secretaries.

Aimmune Therapeutics Uk Limited Address / Contact

Office Address Carrick House
Office Address2 Lypiatt Road
Town Cheltenham
Post code GL50 2QJ
Country of origin United Kingdom

Company Information / Profile

Registration Number 09559128
Date of Incorporation Fri, 24th Apr 2015
Industry Manufacture of basic pharmaceutical products
End of financial Year 31st December
Company age 4 years old
Account next due date Mon, 30th Sep 2019 (1 day left)
Account last made up date Sun, 31st Dec 2017
Next confirmation statement due date Fri, 8th May 2020 (2020-05-08)
Last confirmation statement dated Wed, 24th Apr 2019

Company staff

Eric B.

Position: Director

Appointed: 16 November 2018

Douglas S.

Position: Director

Appointed: 31 March 2017

Susan B.

Position: Director

Appointed: 12 January 2016

Resigned: 16 January 2019

Crowe Clark Whitehill Llp

Position: Corporate Secretary

Appointed: 24 April 2015

Resigned: 22 March 2019

Warren D.

Position: Director

Appointed: 24 April 2015

Resigned: 31 March 2017

Stephen D.

Position: Director

Appointed: 24 April 2015

Resigned: 19 June 2018

People with significant control

The register of PSCs who own or have control over the company consists of 1 name. As BizStats established, there is Aimmune Therapeutics Inc. from Brisbane, United States. This PSC is categorised as "a public company" and has 75,01-100% shares. This PSC and has 75,01-100% shares.

Aimmune Therapeutics Inc.

8000 Marina Boulevard, Suite 300, Brisbane, California, 94005-1884, United States

Legal authority Laws Of State Of Delaware
Legal form Public Company
Notified on 6 April 2016
Nature of control: 75,01-100% shares

Company filings

Filing category
Accounts Annual return Confirmation statement Incorporation Officers
Confirmation statement with no updates Wed, 24th Apr 2019
filed on: 1st, May 2019
Free Download (3 pages)

Company search